FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a new method of producing (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-((7R)-7-hydroxy-5,6,7,8-tetrahydronaphthalene-1-yl)acetamide, represented by Formula (I), which is a heterocyclidene acetamide derivative. The method includes carrying out a condensation reaction of a compound represented by Formula (B), or a salt thereof, and a compound represented by Formula (CA-1), using DMT-MM as a condensing reagent, obtaining a compound represented by Formula (I)
Formula (I):
[C118]
Formula (B):
[C119]
Formula (CA-1):
[C120]
EFFECT: new method of more easily obtaining the compound represented by formula (I) with high yield.
1 cl, 3 dwg, 30 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUND OF FGFR INHIBITOR IN SOLID FORM AND METHOD OF ITS PREPARATION | 2020 |
|
RU2810067C2 |
OXASPIRO DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINES | 2016 |
|
RU2733373C2 |
FGFR INHIBITOR AND ITS MEDICAL USE | 2018 |
|
RU2771311C2 |
PYRIMIDOIMIDAZOLE COMPOUNDS USED AS DNA-RK INHIBITORS | 2020 |
|
RU2796163C1 |
FLUOROVINYLBENZAMIDE COMPOUND AS A PD-L1 IMMUNOMODULATOR | 2020 |
|
RU2789450C1 |
ALPHA- AND BETA-UNSATURATED AMIDE COMPOUND-A BENZOTRIAZOLE DERIVATIVE USED AS A TGF-ΒRI INHIBITOR | 2017 |
|
RU2737737C2 |
TLR8 AGONIST | 2019 |
|
RU2800877C2 |
DERIVATIVE WITH CONDENSED RING AS A RECEPTOR INHIBITOR | 2018 |
|
RU2748993C1 |
NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
PYRIDOPYRIMIDINE COMPOUNDS ACTING AS DOUBLE INHIBITORS OF mTORC 1/2 | 2018 |
|
RU2771201C2 |
Authors
Dates
2024-02-07—Published
2020-06-10—Filed